ARTICLE SUMMARY:
Proteus founder Andrew Thompson’s grim take on prospects for digital disruption in healthcare; Expert tips for innovators seeking FDA Breakthrough status; Device firms sidelined in OIG’s new value-based care anti-kickback protections; CDRH’s new digital simulation system; Digital Diagnostics achieves regulatory & reimbursement milestones for AI technology; New CMS ESRD model aimed at encouraging home-based kidney care. These stories and more in the current issue of Market Pathways.
